Investors
3 investorsAll
Early stage
Mid stage
Late stage
Early stage· 2
Tianran Liu
General Partner at Vertex Ventures China | China-originated Innovation × Global Capital, Pharma & Markets | Biotech, Life Sciences & Healthcare
Board Observer
early stage
5 investments
Oct 2020
Claire Chin, MD MBA
Head of Financial Investment of Biotechnology & Life Science Techology; Ex Consultant; Former Physician; Kellogg MBA
early stage
3 investments
2019
Investor geography2 countries
Investor activity2019–2022 · investors recorded per year
Recent (last 2y)Earlier
Frequently asked questions
Who invested in AnHeart Therapeutics?
AnHeart Therapeutics has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did AnHeart Therapeutics last raise funding?
The most recent investment in AnHeart Therapeutics recorded on gritt.io was in June 2022.
When was AnHeart Therapeutics founded?
AnHeart Therapeutics was founded in 2018.
What industry is AnHeart Therapeutics in?
AnHeart Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is AnHeart Therapeutics based?
AnHeart Therapeutics is headquartered in New York, United States.